Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $2,909 - $3,403
-39 Reduced 11.78%
292 $22,000
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $19,485 - $22,687
-242 Reduced 42.23%
331 $28,000
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $6,008 - $6,796
75 Added 15.06%
573 $50,000
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $31,162 - $34,458
-391 Reduced 43.98%
498 $44,000
Q3 2021

Nov 08, 2021

BUY
$81.78 - $95.14 $6,378 - $7,420
78 Added 9.62%
889 $73,000
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $33,158 - $36,624
389 Added 92.18%
811 $74,000
Q1 2021

Apr 28, 2021

BUY
$83.5 - $98.47 $26,636 - $31,411
319 Added 309.71%
422 $36,000
Q4 2020

Feb 09, 2021

BUY
$78.07 - $94.43 $5,699 - $6,893
73 Added 243.33%
103 $10,000
Q3 2020

Nov 02, 2020

BUY
$82.14 - $91.0 $328 - $364
4 Added 15.38%
30 $3,000
Q2 2020

Aug 11, 2020

SELL
$80.93 - $91.1 $1,618 - $1,822
-20 Reduced 43.48%
26 $2,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $2,968 - $4,158
-42 Reduced 47.73%
46 $4,000
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $3,627 - $4,100
43 Added 95.56%
88 $8,000
Q3 2019

Oct 17, 2019

BUY
$85.54 - $94.26 $3,849 - $4,241
45 New
45 $4,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.